Facial Erythema Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Request Brochure Request Discount

Report Code: ZMR-2134 | Report Format : | Status : Upcoming |

Abstract

Facial Erythema Treatment Market: Overview

Mostly, in the fair population facial erythema is seen. It is a condition where the face becomes red. The cause of this redness on the face is the dilation of the cutaneous blood vessels and the rise in the blood flow. In case of the dark skinned people, the facial erythema goes undiagnosed. Factors that cause the facial erythema, include the common skin diseases such as perioral dermatitis, rosacea, and systemic illness.

Facial Erythema Treatment Market: Facts

The US FDA has approved the Rhofade, Allergan (oxymetazoline hydrochloride 1% cream) for the cure of the persistent facial erythema which is generally associated with the rosacea. It is the first alpha1A adrenoceptor agonist that is approved by the FDA for the treatment of the persistent facial erythema.

Facial Erythema Treatment Market: Segmentation

The global market for the facial erythema treatment is fragmented into drug type, disease type, and distribution channel. On the basis of the drug type, the global market is segregated into antihistamines, antibiotics, calcineurin inhibitors, emollients, antifungal, and corticosteroids. On the basis of disease type, the market is categorized into papulopustular, ocular, erythematotelangiectatic, and phymatous. On the basis of the distribution channel, the market is divided into online pharmacies, hospital pharmacies, retail pharmacies, and others.

Facial Erythema Treatment Market: Growth Factors

The major factors that are contributing to the facial erythema treatment market are an increased rate of patient population, growing smoking population, increased consumption of the alcohol, changing climatic conditions, introduction to new products and the large pipeline of the drugs. Another factor that is contributing to the market growth is the technological developments that are made in this field. There are factors that are restraining the growth of the facial erythema treatment market which includes the growing generic competition and the regulations that are implemented on the approvals of the product.

Facial Erythema Treatment Market: Regional Analysis

The geographical diversification of the global facial erythema treatment market includes the Western European, Eastern Europe, Latin America, Middle East and Africa, and North America regions. The region that dominates the facial erythema treatment market is North America due to the factors such as the adoption of the treatments, the changing lifestyles of the people, and the increased number of fair population triggers the growth of the market in this region. The region that holds the second place is Europe and the factors that support this growth are the increasing consumption of the alcohol and the rise in the research and development activities. In the Asia Pacific region, the factors that support the growth of the market are changing lifestyle, increase in the growth of the population, the large influence of the Western lifestyle, a large pool of targeted patients, and the increase in the research and development activities.

Facial Erythema Treatment Market: Competitive Players

The key market players that are involved in the facial erythema treatment market include Astellas Pharma Inc., Meda Pharmaceuticals, Pfizer Inc., Sanofi S.A., Valeant Pharmaceuticals International, Inc., Anacor Pharmaceuticals Inc., Galderma S.A., Novartis International AG, and Regeneron Pharmaceuticals Inc.

Facial Erythema Treatment Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Sep-2018 | Price : $ 4899.00 | Pages: 160 | Report Code: ZMR-3361 | Report Format:

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and ...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.